Latest Roche Molecular Diagnostics Stories
Molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer PLEASANTON, Calif., May 11, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX:
Provides Researchers with Global Access to Roche Biochemical Reagents Product Portfolio ST.
New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide PLEASANTON, Calif., Jan.
The cobas® Liat System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less PLEASANTON, Calif., Dec.
Panel composed of CDISC experts from Roche, Medivation, Santen, Biomarin and Clinovo will discuss and share ideas around the topic: “CDISC for Medical Device Companies: Progress Made and Best
- A handkerchief.
- In general, any miraculous portrait of Christ.